191 related articles for article (PubMed ID: 2137857)
21. Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505.
Norman KE; Williams TJ; Rossi AG
Br J Pharmacol; 1997 Apr; 120(7):1286-93. PubMed ID: 9105704
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action.
Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB
Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287
[TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage.
Rosengren S; Bong GW; Firestein GS
J Immunol; 1995 May; 154(10):5444-51. PubMed ID: 7730646
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF.
Flamand N; Lefebvre J; Lapointe G; Picard S; Lemieux L; Bourgoin SG; Borgeat P
J Leukoc Biol; 2006 May; 79(5):1043-51. PubMed ID: 16501051
[TBL] [Abstract][Full Text] [Related]
25. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
de Haas CJ; Veldkamp KE; Peschel A; Weerkamp F; Van Wamel WJ; Heezius EC; Poppelier MJ; Van Kessel KP; van Strijp JA
J Exp Med; 2004 Mar; 199(5):687-95. PubMed ID: 14993252
[TBL] [Abstract][Full Text] [Related]
26. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
Calderaro V; Parrillo C; Giovane A; Greco R; Matera MG; Berrino L; Rossi F
J Pharmacol Exp Ther; 1992 Nov; 263(2):579-87. PubMed ID: 1331406
[TBL] [Abstract][Full Text] [Related]
27. Effects of proinflammatory mediators on canine neutrophil chemotaxis and aggregation.
Strøm H; Thomsen MK
Vet Immunol Immunopathol; 1990 Jul; 25(3):209-17. PubMed ID: 2396362
[TBL] [Abstract][Full Text] [Related]
28. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin.
Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R
Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
30. Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.
Flamand N; Picard S; Lemieux L; Pouliot M; Bourgoin SG; Borgeat P
Br J Pharmacol; 2006 Oct; 149(4):385-92. PubMed ID: 16967052
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory peptides inhibit synthesis of platelet-activating factor.
Camussi G; Tetta C; Turello E; Baglioni C
Prog Clin Biol Res; 1990; 349():69-80. PubMed ID: 2204939
[No Abstract] [Full Text] [Related]
32. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1.
Getting SJ; Flower RJ; Perretti M
Br J Pharmacol; 1997 Mar; 120(6):1075-82. PubMed ID: 9134220
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic applications of antiflammin peptides in experimental ocular inflammation.
Chan CC; Tuaillon N; Li Q; Shen DF
Ann N Y Acad Sci; 2000; 923():141-6. PubMed ID: 11193752
[TBL] [Abstract][Full Text] [Related]
34. [Effect of ginkgolide B on platelet-activating factor induced activation of rat polymorphonuclear leukocytes].
Nie ZG; Wang WJ
Yao Xue Xue Bao; 2003 Feb; 38(2):98-102. PubMed ID: 12778742
[TBL] [Abstract][Full Text] [Related]
35. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
36. Chemotactic mediator requirements in lung injury following skin burns in rats.
Piccolo MT; Wang Y; Sannomiya P; Piccolo NS; Piccolo MS; Hugli TE; Ward PA; Till GO
Exp Mol Pathol; 1999 Aug; 66(3):220-6. PubMed ID: 10486240
[TBL] [Abstract][Full Text] [Related]
37. Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro.
Rosenbaum JT; Hartiala KT; Webster RO; Howes EL; Goldstein IM
Am J Pathol; 1983 Dec; 113(3):291-9. PubMed ID: 6228151
[TBL] [Abstract][Full Text] [Related]
38. A novel anti-inflammatory peptide from human lipocortin 5.
Perretti M; Becherucci C; Mugridge KG; Solito E; Silvestri S; Parente L
Br J Pharmacol; 1991 Jun; 103(2):1327-32. PubMed ID: 1832064
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
40. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides.
Marastoni M; Scaranari V; Romualdi P; Donatini A; Ferri S; Tomatis R
Arzneimittelforschung; 1993 Sep; 43(9):997-1000. PubMed ID: 8240467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
